Pain after operations for radius fractures.

Brachial plexus block and rebound pain after radius fixation with a polar plate.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2016-000684-16-NO

Enrollment

Registered

2016-04-04

Start date

2016-05-25

Completion date

Unknown

Last updated

2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after radius fracture fixation by a volar plate.

Interventions

Product Name: DexaGalen Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Injection Route of administration of the placebo: Intravenous use Trade Name: Arcoxia Product N

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Radius fractures planned operated with a polar plate fixation. Age 18-65. ASA class 1 and 2. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Chronic pain. Neurological disease. Nerve impairment of the upper limb. Diabetes. Any known allergic reaction to any medication in the study.

Design outcomes

Primary

Measure	Time frame
Main Objective: To find out if single doses of dexamethasone and etoricoxib will reduce pain after radius fracture operation. ;Secondary Objective: To find out if single doses of dexamethasone and etoricoxib will reduce analgesic consumption and improve daily function after radius fracture operations.;Primary end point(s): Difference in highest VNRS score first 24 hours after the operation.;Timepoint(s) of evaluation of this end point: First 24 hours after the operation.	—

Measure

Time frame

Main Objective: To find out if single doses of dexamethasone and etoricoxib will reduce pain after radius fracture operation. ;Secondary Objective: To find out if single doses of dexamethasone and etoricoxib will reduce analgesic consumption and improve daily function after radius fracture operations.;Primary end point(s): Difference in highest VNRS score first 24 hours after the operation.;Timepoint(s) of evaluation of this end point: First 24 hours after the operation.

—

Secondary

Measure	Time frame
Secondary end point(s): Differences in VNRS scores at different times after the operation. Differences in analgesic consumption after the operation. Differences in daily function after the operation.;Timepoint(s) of evaluation of this end point: 30 min, 1 hour, 2 hrs, 4 hrs, 8 hrs, 24 hrs, 36 hrs, 72 hrs, 7 days, 6 weeks, 6 months, 1 year	—

Countries

Norway

Contacts

Public ContactAnne Holmberg, Dept of anesthesia

Oslo Universitetssykehus

anne.holmberg@ous-hf.no4748127279

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026